| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.33 | 0.07 |